Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Inventory: 2010-2015

Historic Inventory for Lineage Cell Therapeutics (LCTX) over the last 6 years, with Dec 2015 value amounting to $1,000.

  • Lineage Cell Therapeutics' Inventory fell 99.62% to $1,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $1,000, marking a year-over-year decrease of 99.62%. This contributed to the annual value of $1,000 for FY2015, which is 99.62% down from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Inventory of $1,000 as of FY2015, which was down 99.62% from $266,000 recorded in FY2014.
  • In the past 5 years, Lineage Cell Therapeutics' Inventory registered a high of $266,000 during FY2014, and its lowest value of $1,000 during FY2015.
  • In the last 3 years, Lineage Cell Therapeutics' Inventory had a median value of $178,694 in 2013 and averaged $148,565.
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 223.04% in 2013, then tumbled by 99.62% in 2015.
  • Lineage Cell Therapeutics' Inventory (Yearly) stood at $51,174 in 2011, then increased by 8.09% to $55,316 in 2012, then surged by 223.04% to $178,694 in 2013, then spiked by 48.86% to $266,000 in 2014, then slumped by 99.62% to $1,000 in 2015.